Synonym
Motretinide; Tasmaderm; Ro 11-1430; Ro-11-1430; Ro11-1430;
IUPAC/Chemical Name
(2E,4E,6E,8E)-N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide
InChi Key
IYIYMCASGKQOCZ-DJRRULDNSA-N
InChi Code
InChI=1S/C23H31NO2/c1-8-24-23(25)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(26-7)20(6)19(21)5/h9-15H,8H2,1-7H3,(H,24,25)/b11-9+,13-12+,16-10+,17-14+
SMILES Code
O=C(NCC)/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C=C(OC)C(C)=C1C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
353.50
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Lassus A, Juvakoski T, Lauharanta J. Motretinide versus benzoyl peroxide in the treatment of acne vulgaris. Dermatologica. 1984;168(4):199-201. PubMed PMID: 6233188.
2: Reiners J, Löfberg B, Kraft JC, Kochhar DM, Nau H. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice. Reprod Toxicol. 1988;2(1):19-29. PubMed PMID: 2980988.
3: Strauss JS. Overview of other topical retinoids. J Am Acad Dermatol. 1986 Oct;15(4 Pt 2):905-6. PubMed PMID: 2945845.
4: Mezick JA, Bhatia MC, Capetola RJ. Topical and systemic effects of retinoids on horn-filled utriculus size in the rhino mouse. A model to quantify "antikeratinizing" effects of retinoids. J Invest Dermatol. 1984 Aug;83(2):110-3. PubMed PMID: 6206163.
5: Marks R, Black D, Pearse AD, Hill S. Techniques for assessing the activity of topically applied retinoids. J Am Acad Dermatol. 1986 Oct;15(4 Pt 2):810-6. PubMed PMID: 3534018.
6: Gollnick H. New indications and new retinoids. Dermatologica. 1987;175 Suppl 1:182-95. Review. PubMed PMID: 3319725.
7: Teelmann K, Bollag W. The relevance of the mouse papilloma test as a predictor of retinoid activity in human psoriasis. Dermatologica. 1990;180(1):30-5. PubMed PMID: 2407574.
8: Athanassiades TJ. Adjuvant effect of vitamin A palmitate and analogs on cell-mediated immunity. J Natl Cancer Inst. 1981 Nov;67(5):1153-6. PubMed PMID: 7029099.
9: Zeng Y, Zhou HM, Xu SP. Inhibitory effect of retinoids on Epstein-Barr virus induction in Raji cells. Intervirology. 1981;16(1):29-32. PubMed PMID: 6276324.
10: Smolin G, Okumoto M. Vitamin A acid and corneal epithelial wound healing. Ann Ophthalmol. 1981 May;13(5):563-6. PubMed PMID: 7258949.
11: Khoury S. Retinoids in superficial bladder tumours update. Prog Clin Biol Res. 1984;162B:347-54. PubMed PMID: 6209722.
12: Du CZ, Su XL, Xu YT. [A comparison of the toxicities of 4-(ethoxycarbophenyl) retinamide and some other retinoids]. Yao Xue Xue Bao. 1982 May;17(5):331-7. Chinese. PubMed PMID: 6960639.
13: Zouboulis CC. Retinoids--which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol. 2001 Sep-Oct;14(5):303-15. Review. PubMed PMID: 11586072.
14: Hill DL, Struck RF. Pharmacologic disposition of chemopreventive retinoids (review). Anticancer Res. 1983 May-Jun;3(3):171-80. Review. PubMed PMID: 6347031.
15: Borek C, Miller RC, Geard CR, Guernsey DL, Smith JE. In vitro modulation of oncogenesis and differentiation by retinoids and tumor promoters. Carcinog Compr Surv. 1982;7:277-84. PubMed PMID: 6461410.
16: Nordin K, Fredriksson T, Rylander C. Ro 11-1430, a new retinoic acid derivative for the topical treatment of acne. Dermatologica. 1981;162(2):104-11. PubMed PMID: 6454596.
17: Radner BS, Kennedy AR. Effects of agents known to antagonize the enhancement of in vitro transformation by 12-tetradecanoyl-phorbol-13-acetate (TPA) on the TPA suppression of metabolic cooperation. Cancer Lett. 1984 Dec;25(2):139-44. PubMed PMID: 6509433.
18: Hard GC, Ogiu T. Null effects of vitamin A analogs on the dimethylnitrosamine kidney tumor model. Carcinogenesis. 1984 May;5(5):665-9. PubMed PMID: 6586320.
19: Orfanos CE, Gollnick H, Tsambaos D. [New aspects and developments in antipsoriasis retinoid therapy]. Hautarzt. 1981 Jun;32(6):275-80. German. PubMed PMID: 7263232.
20: Oegema TR Jr, Parzych SM. Effect of the retinoic acid analog Ro 11-1430 on proteoglycans of swarm rat chondrosarcoma. J Natl Cancer Inst. 1981 Jul;67(1):99-106. PubMed PMID: 6942198.
